| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/1989 | EP0303688A1 Hybrid genes incorporating a dna fragment containing a gene coding for an insecticidal protein, plasmids, transformed cyanobacteria expressing such protein and method for use as a biocontrol agent |
| 02/22/1989 | EP0216860A4 Stereoregular polynucleotide-binding polymers. |
| 02/21/1989 | US4806626 α-amylase inhibitor |
| 02/21/1989 | US4806523 Cartilage-inducing factors |
| 02/21/1989 | US4806492 Polypeptide tumor inhibitors and antibodies thereto |
| 02/21/1989 | US4806476 Removing calcium ions to destabilize cell membranes |
| 02/21/1989 | US4806465 Cytoplasmic antigens of candida albicans and methods of using the same |
| 02/21/1989 | US4806348 Method for inducing antibody formation |
| 02/21/1989 | US4806343 Cryogenic protectant for proteins |
| 02/21/1989 | US4806336 Human intestinal hormone and its use |
| 02/21/1989 | CA1250400A1 Peptides having influence on memory processes, processes for producing them and pharmaceutical compositions containing them |
| 02/21/1989 | CA1250399A1 Peptide synthesis process |
| 02/21/1989 | CA1250234A1 Clinical use of somatostatin analogues |
| 02/15/1989 | EP0303540A1 Factor VIII analog, process for its preparation and composition containing it |
| 02/15/1989 | EP0303538A2 Protein with a vascular activity, derived from monocytes and its analogues, process for its extraction and their uses as therapeutic agents and for the preparation of antibodies |
| 02/15/1989 | EP0303488A2 Biologically active molecules |
| 02/15/1989 | EP0303483A2 Novel lymphokine and compositions thereof |
| 02/15/1989 | EP0303463A2 Method to control leukocyte extravasation |
| 02/15/1989 | EP0303426A2 Novel isolates of bacillus thuringiensis having activity against nematodes |
| 02/15/1989 | EP0303329A1 A process for isolating coagulation factors, and adsorbent material suitable therefor |
| 02/15/1989 | EP0303309A2 A genus-specific Listeria antigen identified by monoclonal antibodies |
| 02/15/1989 | EP0303233A2 Human reg protein |
| 02/15/1989 | EP0303064A2 Phospholipid affinity purification of factor VIII:C |
| 02/15/1989 | EP0303033A2 Molecular cloning and characterization of a further gene sequence coding for human relaxin |
| 02/15/1989 | EP0303028A1 Method for preparing single chain urokinase |
| 02/15/1989 | EP0302928A1 Inorganic filtration membrane modified for protein separation. |
| 02/15/1989 | EP0302925A1 A method for producing factor viii in high yield |
| 02/15/1989 | EP0302892A1 Segmented polypeptide bioeleastomers to modulate elastic modulus. |
| 02/15/1989 | EP0143832B1 Modified crosslinked stroma-free tetrameric hemoglobin |
| 02/14/1989 | US4804746 Administering a decapeptide as a hapten with a carrier and a hapten-carrier binder |
| 02/14/1989 | US4804744 Osteogenic factors |
| 02/14/1989 | US4804742 Osteoporosis treatment of extended duration |
| 02/14/1989 | US4804676 Propioxatins a and b |
| 02/14/1989 | US4804650 Diuretics, vasodilators |
| 02/14/1989 | US4804626 Using immobilized monoclonal antibodies |
| 02/14/1989 | CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 02/14/1989 | CA1250099A1 Immunogens, antibodies, labeled conjugates and related derivatives for lidocaine and analogs thereof |
| 02/14/1989 | CA1250098A1 Ester derivatives of antibiotic l 17046 |
| 02/14/1989 | CA1250097A1 Process for preparing antibiotic l 17046 |
| 02/14/1989 | CA1250096A1 Process for preparing antibiotic l 17392 (deglucoteicoplanin) |
| 02/14/1989 | CA1250094A1 Chemical process for preparing antibiotic l 17054 |
| 02/14/1989 | CA1250092A1 Polypeptide diuretic/vasodilators |
| 02/09/1989 | WO1989001159A1 Receptor membranes |
| 02/09/1989 | WO1989001046A1 Purification of human interleukin-4 expressed in escherichia coli |
| 02/09/1989 | WO1989001045A1 Leishmania-specific antigens, process for preparing them, antigenic profiles containing these antigens and their application to the diagnosis of visceral leishmaniasis |
| 02/09/1989 | WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
| 02/09/1989 | WO1989001040A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 02/09/1989 | WO1989001039A1 A method of directing transgenic expression in animals using a prolactin promoter |
| 02/09/1989 | WO1989001038A1 PRODUCTION OF BIOLOGICALLY ACTIVE FORMS OF CSF USING A BACULOVIRUS (AcNPV)-INSECT CELL EXPRESSION SYSTEM |
| 02/09/1989 | WO1989001037A1 Production of ricin toxins in a baculovirus-insect cell expression system |
| 02/09/1989 | WO1989001036A1 Recombinant dna expression vectors |
| 02/09/1989 | WO1989001028A1 Serum free media for the growth of insect cells and expression of products thereby |
| 02/09/1989 | WO1989001027A1 Lipid microemulsions for culture media |
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 02/09/1989 | WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents |
| 02/09/1989 | WO1989000861A1 Vaccination against rabies-related viruses |
| 02/09/1989 | WO1989000860A1 Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/09/1989 | EP0208772A4 Test for campylobacter. |
| 02/09/1989 | DE3710309A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 02/08/1989 | EP0302801A1 Vaccines of which the characteristic epitope is incorporated in a picorna virus protein, particularly in that of the polio virus |
| 02/08/1989 | EP0302758A1 Viral expression inhibitors |
| 02/08/1989 | EP0302734A2 Continuous processes for modifying biologically active materials and the products therefrom |
| 02/08/1989 | EP0302503A2 Method for the separation and purification of t-PA |
| 02/08/1989 | EP0302469A2 Process for reactivating protein |
| 02/08/1989 | EP0302459A2 Human placenta-derived thermostable cell growth factor and a process for production thereof |
| 02/08/1989 | EP0302456A1 New tissue plasminogen activator |
| 02/08/1989 | EP0302445A2 A novel hypoglycemic and growth-promoting agent |
| 02/08/1989 | EP0302429A1 Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same |
| 02/08/1989 | EP0302381A1 A fused gene having aequorin gene linked to a functional B-galactosidase gene |
| 02/08/1989 | EP0302103A1 Colony stimulating factors having reduced levels of carbohydrate |
| 02/08/1989 | EP0169111B1 Cytotoxic conjugates useful in therapy, and process for obtaining them |
| 02/08/1989 | EP0145775B1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION |
| 02/08/1989 | CN1030939A Promoter for expression of exogenous dna in methyltrophic bacteria, process for preparing same and theiruse |
| 02/08/1989 | CN1030917A Immunosuppressant peptides |
| 02/07/1989 | US4803261 Method for synthesizing a peptide containing a non-peptide |
| 02/07/1989 | US4803165 Nif promoter of fast-growing rhizobium japonicum |
| 02/07/1989 | US4803164 Kinase promoter |
| 02/07/1989 | US4803163 Preparation of a protein fraction exhibiting cell growth-inhibiting activity |
| 02/07/1989 | US4803156 Detection of hepatitis b antibodies |
| 02/07/1989 | US4803155 Monoclonal antibodies to Sclerotinia homoeocarpa |
| 02/07/1989 | CA1249811A1 Rigid coupling compounds |
| 02/07/1989 | CA1249781A1 Methods of concentrating ligands and active membranes used therefor |
| 02/02/1989 | DE3724016A1 Methods for the genetic engineering production of antigens and their use in an approach to confirmatory tests for antibodies in the example of human immunodeficiency virus (HIV) |
| 02/01/1989 | EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections |
| 02/01/1989 | EP0301992A2 Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor |
| 02/01/1989 | EP0301961A1 Specific secretion-excretion-antigens from toxoplasma gondii, expression products therefrom, production processes therefor and their diagnostic and prophylactic applications |
| 02/01/1989 | EP0301954A2 Cloning method and expression of genes constituting functional organised structures |
| 02/01/1989 | EP0301835A1 Purification of human interleukin-4 expressed in Escherichia Coli |
| 02/01/1989 | EP0301670A1 Kluyveromyces as a host strain |
| 02/01/1989 | EP0301669A1 DNA constructs containing a Kluyveromyces alpha-factor leader sequence for directing secretion of heterologous derivatives |
| 02/01/1989 | EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH |
| 02/01/1989 | EP0301484A1 PTH modifications and therapeutic compositions containing them or consisting of them |
| 02/01/1989 | EP0301458A2 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
| 02/01/1989 | EP0301374A2 Process for the purification of the placenta tissue protein PP4 |
| 02/01/1989 | EP0301314A2 A method for the purification of interferon |
| 02/01/1989 | EP0301289A1 Humaner Papillomvirus Typ 41 |
| 02/01/1989 | EP0301083A1 Retroviral expression vectors and methods for producing hbv antigens |
| 02/01/1989 | EP0138948B1 Dna sequence encoding an exo-signal |
| 02/01/1989 | CN1030766A Enkastine-glycopeptide of action having inhibitory encephalinase, process for preparing them and pharamaceutical use |